Objective To observe the effectiveness and safety of mouse nerve growth factor in treatment of spinal muscular atrophy(SMA) in children.
目的观察鼠神经生长因子治疗儿童脊髓性肌萎缩症(SMA)的临床疗效及安全性。
参考来源 - 鼠神经生长因子治疗儿童脊髓性肌萎缩症的临床研究The frequency distributions of clinical type were as follows:Ⅱ-B type 68.6%,Ⅱ-A type 13.8%,Ⅰtype 11.5%,Ⅳtype 3.5%,Ⅲtype 2.5%,Ⅴtype with muscular atrophy 0.2%.
重症肌无力临床分型频数分布为Ⅱ—B型68.6%,Ⅱ—A型13.8%,Ⅰ型11.5%,Ⅳ型3.5%,Ⅲ型2.5%,Ⅴ型伴肌肉萎缩占0.2%。
参考来源 - 构建重症肌无力五脏相关理论数据挖掘模型的研究·2,447,543篇论文数据,部分数据来源于NoteExpress
应用推荐